Search by Drug Name or NDC

    NDC 33342-0250-44 Repaglinide 2 mg/1 Details

    Repaglinide 2 mg/1

    Repaglinide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is REPAGLINIDE.

    Product Information

    NDC 33342-0250
    Product ID 33342-250_7a93246c-9323-40c4-b590-a40dcb133c8c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Repaglinide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Repaglinide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name REPAGLINIDE
    Labeler Name Macleods Pharmaceuticals Limited
    Pharmaceutical Class Glinide [EPC], Potassium Channel Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207209
    Listing Certified Through 2024-12-31

    Package

    NDC 33342-0250-44 (33342025044)

    NDC Package Code 33342-250-44
    Billing NDC 33342025044
    Package 1000 TABLET in 1 BOTTLE (33342-250-44)
    Marketing Start Date 2023-03-22
    NDC Exclude Flag N
    Pricing Information N/A